Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Bansback

Showing results (171-180 of 203) with videos related to

Pageof 21
Sort By:
International Journal of Technology Assessment in Health Care|February 26, 2026
WHAT DO HTA AGENCIES NEED FOR GENERATING HEALTH-RELATED QUALITY OF LIFE EVIDENCE? FINDINGS FROM A GLOBAL SURVEYAnnushiah Vasan Thakumar, Paula Lorgelly, Louise Longworth, et al.
Health Technology Assessment (Winchester, England)|February 27, 2014
Preparatory study for the revaluation of the EQ-5D tariff: methodology reportBrendan Mulhern, Nick Bansback, John Brazier, et al.
The Patient|October 16, 2020
Patient-Oriented Research from the ISDM 2019 Conference: A Legacy Now More Relevant Than EverPatrick M Archambault, Sabrina Guay-Bélanger, Véronique Gélinas, et al.
Thrombosis Research|December 4, 2018
Assessment of atrial fibrillation patients' education needs from patient and clinician perspectives: A qualitative descriptive studyShahrzad Salmasi, Leanne Kwan, Jenny MacGillivray, et al.
The Lancet. HIV|September 24, 2016
Comparative efficacy and safety of first-line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta-analysisSteve Kanters, Marco Vitoria, Meg Doherty, et al.
ACR Open Rheumatology|April 1, 2021
Development of an Implementation Strategy for Patient Decision Aids in Rheumatoid Arthritis Through Application of the Behavior Change WheelClaire E H Barber, Nicole Spencer, Nick Bansback, et al.
Addiction (Abingdon, England)|March 29, 2018
Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trialNick Bansback, Daphne Guh, Eugenia Oviedo-Joekes, et al.
International Journal of Radiation Oncology, Biology, Physics|December 6, 2006
Cost-effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compressionKenneth C Thomas, Bohdan Nosyk, Charles G Fisher, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 25, 2025
Biosimilar Policies and Their Impact on Market Penetration of Adalimumab, Etanercept and Infliximab: A Policy Synthesis and Descriptive Analysis in 13 OECD CountriesAlexander C T Tam, Jasleen Badesha, Daphne P Guh, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 11, 2020
Exploring the Cost Effectiveness of Shared Decision Making for Choosing between Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis in the Netherlands: A State Transition ModelIngrid E H Kremer, Mickael Hiligsmann, Josh Carlson, et al.
Pageof 21

Showing results (171-180 of 203) with videos related to

Sort By:
Pageof 21
International Journal of Technology Assessment in Health Care|February 26, 2026
WHAT DO HTA AGENCIES NEED FOR GENERATING HEALTH-RELATED QUALITY OF LIFE EVIDENCE? FINDINGS FROM A GLOBAL SURVEYAnnushiah Vasan Thakumar, Paula Lorgelly, Louise Longworth, et al.
Health Technology Assessment (Winchester, England)|February 27, 2014
Preparatory study for the revaluation of the EQ-5D tariff: methodology reportBrendan Mulhern, Nick Bansback, John Brazier, et al.
The Patient|October 16, 2020
Patient-Oriented Research from the ISDM 2019 Conference: A Legacy Now More Relevant Than EverPatrick M Archambault, Sabrina Guay-Bélanger, Véronique Gélinas, et al.
Thrombosis Research|December 4, 2018
Assessment of atrial fibrillation patients' education needs from patient and clinician perspectives: A qualitative descriptive studyShahrzad Salmasi, Leanne Kwan, Jenny MacGillivray, et al.
The Lancet. HIV|September 24, 2016
Comparative efficacy and safety of first-line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta-analysisSteve Kanters, Marco Vitoria, Meg Doherty, et al.
ACR Open Rheumatology|April 1, 2021
Development of an Implementation Strategy for Patient Decision Aids in Rheumatoid Arthritis Through Application of the Behavior Change WheelClaire E H Barber, Nicole Spencer, Nick Bansback, et al.
Addiction (Abingdon, England)|March 29, 2018
Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trialNick Bansback, Daphne Guh, Eugenia Oviedo-Joekes, et al.
International Journal of Radiation Oncology, Biology, Physics|December 6, 2006
Cost-effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compressionKenneth C Thomas, Bohdan Nosyk, Charles G Fisher, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 25, 2025
Biosimilar Policies and Their Impact on Market Penetration of Adalimumab, Etanercept and Infliximab: A Policy Synthesis and Descriptive Analysis in 13 OECD CountriesAlexander C T Tam, Jasleen Badesha, Daphne P Guh, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 11, 2020
Exploring the Cost Effectiveness of Shared Decision Making for Choosing between Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis in the Netherlands: A State Transition ModelIngrid E H Kremer, Mickael Hiligsmann, Josh Carlson, et al.
Pageof 21